Prenatal exposure to buprenorphine or methadone and adverse neurodevelopmental outcomes: population based cohort study

CONCLUSIONS: The findings of this study suggest no increased risk of long term adverse neurodevelopmental outcomes among children with prenatal exposure to buprenorphine versus methadone, further supporting buprenorphine as a safe treatment option for opioid use disorder during pregnancy.

via https://pubmed.ncbi.nlm.nih.gov/41985931/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1L37KAMf2b_g4WEK3LmdFuKZu9pO3cN7u4ZmO9PPCPeBLMIw1q&fc=None&ff=20260428010904&v=2.19.0.post6+133c1fe